1Vote!
Washington Post (Free subscription) | 05/09/2008
As a senior executive at Adams Respiratory Therapeutics, John S. Thievon tackled the challenge of launching a pricey decongestant in a marketplace filled with cheap generics. Ultimately that drug, Mucinex, trampled its competition.
+Vote!
Financial Time (Free subscription) | 29/07/2008
Reckitt Benckiser has cut 100 jobs in five months at its new US healthcare business, Adams Respiratory Therapeutics, which it hopes will give it a platform to roll out...
+Vote!
Financial Time (Free subscription) | 28/07/2008
Reckitt Benckiser has cut 100 jobs in five months at its new US healthcare business, Adams Respiratory Therapeutics
+Vote!
News On Women (Free subscription) | 28/05/2008
Schering Plough Corporation (NYSE: SGP) appointed Janet Barth Vice President, Investor Relations. Janet had been Senior Vice President, Investor Relations at Adams Respiratory Therapeutics. Read more about it in the prnewswire press release.
+Vote!
PR News Wire (Free subscription) | 24/01/2008
CHESTER, N.J. and SLOUGH, England, Jan. 24 /PRNewswire-FirstCall/ --
Reckitt Benckiser Group plc (RB.L) ("Reckitt Benckiser") announced today
that it has completed its previously announced cash tender offer (the
"Offer") for all outstanding shares of common stock (the "Shares") of Adams
Respiratory Therapeutics, Inc. (Nasdaq: ) ("Adams"). The Offer expired,
as scheduled, at midnight, New York City...
+Vote!
Reuters UK (Free subscription) | 08/01/2008
(Reuters) - Adams Respiratory Therapeutics and Britain's Reckitt Benckiser Group said they received antitrust approval from U.S. regulators for the acquisition of the U.S.-based drugmaker by the British company.
+Vote!
PR News Wire (Free subscription) | 08/01/2008
SLOUGH, U.K. and CHESTER, N.J., Jan. 8 /PRNewswire-FirstCall/ --
Reckitt Benckiser Group plc (RB.L) ("Reckitt Benckiser") and Adams
Respiratory Therapeutics, Inc. (Nasdaq: ) ("Adams") announced today
that they have received early termination of the waiting period under the
Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) relating to the
previously announced tender offer to purchase all of...
+Vote!
Red Orbit (Free subscription) | 21/12/2007
CHESTER, N.J. and SLOUGH, England, Dec. 21 /PRNewswire-FirstCall/ -- Reckitt Benckiser Group plc (RB.L) ("Reckitt Benckiser"), today commenced its previously announced cash tender offer (the "Offer") for all of the outstanding shares of Adams Respiratory Therapeutics, Inc. ("Adams").
+Vote!
Scotsman.com (Free subscription) | 12/12/2007
JP MORGAN yesterday raised its price target on Reckitt Benckiser to £31.50 from £30, saying the group's acquisition of US drugs group Adams Respiratory Therapeutics would help it reach its goal of doubling sales by 2012.
+Vote!
Fool.com (Free subscription) | 11/12/2007
Reckitt Benckiser purchases Adams Respiratory Therapeutics for $2.3 billion.
+Vote!
Market Wire - Investment Opinion (Free subscription) | 11/12/2007
WESTON, FL (MARKET WIRE) Wall Street News Alert's "stocks to watch" this morning are: ER Urgent Care Centers (PINKSHEETS: ERUC), THQ Inc. (NASDAQ: THQI), Claymont Steel Holdings, Inc. (NASDAQ: PLTE) and Adams Respiratory Therapeutics (NASDAQ: ARXT).
+Vote!
DealBook (Free subscription) | 11/12/2007
Britain's Reckitt Benckiser, the world's largest household products manufacturer, agreed Monday to buy U.S. cough and congestion medicine group Adams Respiratory Therapeutics for $60 a share in cash, or $2.3 billion, The move, which marks Reckitt's entry into the U.S. healthcare market, comes as the maker of Lysol disinfectant is expanding into healthcare. The takeover follows [...]
+Vote!
Financial Time (Free subscription) | 11/12/2007
Reckitt Benckiser, the UK household goods maker, yesterday agreed to buy Adams Respiratory Therapeutics, a small US pharmaceuticals group, for £1.1bn ($2.3bn) as...
+Vote!
Financial Time (Free subscription) | 11/12/2007
Reckitt Benckiser, the UK household goods maker, yesterday agreed to buy Adams Respiratory Therapeutics, a small US pharmaceutical group, for $2.3bn as it outlined...